Ceo
Current-Developed a platform based on QAOA and GBS for protein pruning and binding, and used this platform for binding work around SARS-CoV-2 research extensively, including for immune protein interactions such as the SARS-CoV-2 spike and SP-D -Deployed this platform on various cloud and quantum cloud systems, ranging from superconducting, ion trap, photonic, and annealing systems and utilizing not only AWS, but localized and HPC resources as well